Suppr超能文献

与低密度脂蛋白受体结合的载脂蛋白B100的结构

Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor.

作者信息

Reimund Mart, Dearborn Altaira D, Graziano Giorgio, Lei Haotian, Ciancone Anthony M, Kumar Ashish, Holewinski Ronald, Neufeld Edward B, O'Reilly Francis J, Remaley Alan T, Marcotrigiano Joseph

机构信息

Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Structural Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

出版信息

Nature. 2025 Feb;638(8051):829-835. doi: 10.1038/s41586-024-08223-0. Epub 2024 Dec 11.

Abstract

Apolipoprotein B100 (apoB100) is a structural component of low-density lipoprotein (LDL) and a ligand for the LDL receptor (LDLR). Mutations in apoB100 or in LDLR cause familial hypercholesterolaemia, an autosomal dominant disease that is characterized by a marked increase in LDL cholesterol (LDL-C) and a higher risk of cardiovascular disease. The structure of apoB100 on LDL and its interaction with LDLR are poorly understood. Here we present the cryo-electron microscopy structures of apoB100 on LDL bound to the LDLR and a nanobody complex, which can form a C-symmetric, higher-order complex. Using local refinement, we determined high-resolution structures of the interfaces between apoB100 and LDLR. One binding interface is formed between several small-ligand-binding modules of LDLR and a series of basic patches that are scattered along a β-belt formed by apoB100, encircling LDL. The other binding interface is formed between the β-propeller domain of LDLR and the N-terminal domain of apoB100. Our results reveal how both interfaces are involved in LDL dimer formation, and how LDLR cycles between LDL- and self-bound conformations. In addition, known mutations in either apoB100 or LDLR, associated with high levels of LDL-C, are located at the LDL-LDLR interface.

摘要

载脂蛋白B100(apoB100)是低密度脂蛋白(LDL)的一种结构成分,也是低密度脂蛋白受体(LDLR)的配体。apoB100或LDLR中的突变会导致家族性高胆固醇血症,这是一种常染色体显性疾病,其特征是低密度脂蛋白胆固醇(LDL-C)显著升高以及心血管疾病风险增加。人们对LDL上的apoB100结构及其与LDLR的相互作用了解甚少。在此,我们展示了与LDLR和纳米抗体复合物结合的LDL上的apoB100的冷冻电子显微镜结构,该复合物可形成C对称的高阶复合物。通过局部精修,我们确定了apoB100与LDLR之间界面的高分辨率结构。一个结合界面在LDLR的几个小配体结合模块与一系列沿着由apoB100形成的环绕LDL的β带分散的碱性斑块之间形成。另一个结合界面在LDLR的β螺旋桨结构域与apoB100的N端结构域之间形成。我们的结果揭示了这两个界面如何参与LDL二聚体的形成,以及LDLR如何在LDL结合构象和自身结合构象之间循环。此外,与高水平LDL-C相关的apoB100或LDLR中的已知突变位于LDL-LDLR界面处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验